These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 369880)

  • 1. Prostacyclin (PGI2) activity in rat kidney-stimulated by angiotensin II.
    Silberbauer K; Sinzinger H; Winter M
    Exp Mol Pathol; 1979 Apr; 30(2):242-54. PubMed ID: 369880
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostacyclin activity in rat kidney stimulated by angiotensin II.
    Silberbauer K; Sinzinger H; Winter M
    Br J Exp Pathol; 1979 Feb; 60(1):38-44. PubMed ID: 380621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-II-stimulated release of thromboxane A2 and prostacyclin (PGI2) in isolated, perfused kidneys of spontaneously hypertensive rats.
    Shibouta Y; Inada Y; Terashita Z; Nishikawa K; Kikuchi S; Shimamoto K
    Biochem Pharmacol; 1979 Dec; 28(24):3601-9. PubMed ID: 394747
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin II-induced renal prostacyclin release suppresses platelet aggregation in the anesthetized dog.
    Shebuski RJ; Aiken JW
    Adv Prostaglandin Thromboxane Res; 1980; 7():1149-52. PubMed ID: 6989184
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of furosemide on prostacyclin-like antiaggregatory release from vessel wall and renal cortex.
    Weithmann KU
    Pharmacol Res Commun; 1982 May; 14(5):391-9. PubMed ID: 7051051
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of insulin treatment on prostacyclin in experimental diabetes.
    Harrison HE; Reece AH; Johnson M
    Diabetologia; 1980 Jan; 18(1):65-8. PubMed ID: 6988267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mechanism of angiotensin II induced release of prostacyclin.
    Swies J; Radomski M; Gryglewski RJ
    Pharmacol Res Commun; 1981 Jan; 13(1):37-40. PubMed ID: 7012845
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhanced prostacyclin synthesis in acute human kidney transplant rejection.
    Leithner C; Sinzinger H; Silberbauer K; Wolf A; Stummvoll HK; Pinggera W
    Proc Eur Dial Transplant Assoc; 1980; 17():424-8. PubMed ID: 7017684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortex and medulla of rat kidney generate different amounts of PG I2-like activity.
    Silberbauer K; Sinzinger H
    Thromb Res; 1978 Dec; 13(6):1111-8. PubMed ID: 373158
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination, source, metabolism, and functional role of renal prostaglandins.
    Frölich JC; Walker LA
    Clin Exp Hypertens (1978); 1980; 2(3-4):709-28. PubMed ID: 7000467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of prostaglandins in the kidney.
    Sun FF; Taylor BM; McGuire JC; Wong PY
    Kidney Int; 1981 Jun; 19(6):760-70. PubMed ID: 6790807
    [No Abstract]   [Full Text] [Related]  

  • 12. Formation and metabolism of prostaglandins in the kidney.
    Anggård E; Oliw E
    Kidney Int; 1981 Jun; 19(6):771-80. PubMed ID: 6790808
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet-derived growth factor and prostacyclin in kidney transplant rejection.
    Sinzinger H; Zidek T; Foegh ML
    Transplant Proc; 1987 Aug; 19(4 Suppl 5):102-7. PubMed ID: 3303560
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin-induced release of a prostacyclin-like substance from the lungs.
    Dusting GJ
    J Cardiovasc Pharmacol; 1981; 3(1):197-206. PubMed ID: 6160349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic metabolism of prostacyclin (PGI2) in the rabbit: formation of a potent novel inhibitor of platelet aggregation.
    Wong PY; Malik KU; Desiderio DM; McGiff JC; Sun FF
    Biochem Biophys Res Commun; 1980 Mar; 93(2):486-94. PubMed ID: 6992772
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduced platelet aggregation by pentoxifylline stimulated prostacyclin release.
    Weithmann KU
    Vasa; 1981; 10(3):249-52. PubMed ID: 7025499
    [No Abstract]   [Full Text] [Related]  

  • 17. Vascular prostacyclin release and metabolic derangement in diabetes.
    Harrison HE; Johnson M
    Horm Metab Res Suppl; 1981; 11():43-9. PubMed ID: 7033096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-keto PGE1: a possible metabolite of prostacyclin having platelet antiaggregatory effects.
    Quilley CP; McGiff JC; Lee WH; Sun FF; Wong PY
    Hypertension; 1980; 2(4):524-8. PubMed ID: 6995292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II stimulation of renal prostaglandin synthesis elevates circulating prostacyclin in the dog.
    Shebuski RJ; Aiken JW
    J Cardiovasc Pharmacol; 1980; 2(5):667-77. PubMed ID: 6157958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific binding sites in the rabbit kidney for prostaglandin A.
    Attallah AA; Lee JB
    Prostaglandins; 1973 Nov; 4(5):703-9. PubMed ID: 4205599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.